Status:
COMPLETED
Vitamin D Supplementation and PTH Response Among Malaysian Adults
Lead Sponsor:
IMU University, Malaysia
Conditions:
Healthy
Eligibility:
FEMALE
20-45 years
Phase:
EARLY_PHASE1
Brief Summary
This clinical trial was designed to determine the efficacy of vitamin D supplementation on plasma 25-hydroxyvitamin D \[25(OH)D\] and intact parathyroid hormone (PTH) concentrations of Malaysian femal...
Detailed Description
After being informed regarding the study protocol and requirements, participants given informed consent were interviewed using a questionnaire for collection of background data and medical history as ...
Eligibility Criteria
Inclusion
- three major ethnic groups (Malay, Chinese, Indian)
- age 20-45 years
Exclusion
- any diseases or conditions that may affect vitamin D metabolism, such as diabetes, cardiovascular diseases, bone diseases, autoimmune diseases, had major gastrointestinal surgery and diagnosed primary hyperparathyroidism
- medications that might affect vitamin D metabolism, such as insulin, thiazide diuretics, prednisolone, biphosphonates, tamoxifen and phenytoin
- pregnant and lactating women
Key Trial Info
Start Date :
July 10 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT05281107
Start Date
July 10 2015
End Date
October 1 2016
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
International Medical University
Kuala Lumpur, Kuala Lumpur, Malaysia, 57000